These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 21264968)

  • 1. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
    Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
    Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates.
    Yoshimura Y; Nudelman AS; Levery SB; Wandall HH; Bennett EP; Hindsgaul O; Clausen H; Nishimura S
    Glycobiology; 2012 Mar; 22(3):429-38. PubMed ID: 22042768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody.
    Matsushita T; Ohyabu N; Fujitani N; Naruchi K; Shimizu H; Hinou H; Nishimura S
    Biochemistry; 2013 Jan; 52(2):402-14. PubMed ID: 23259747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
    Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
    J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
    Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
    Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of peptide substrates for mucin-type O-glycosylation.
    Kirnarsky L; Nomoto M; Ikematsu Y; Hassan H; Bennett EP; Cerny RL; Clausen H; Hollingsworth MA; Sherman S
    Biochemistry; 1998 Sep; 37(37):12811-7. PubMed ID: 9737858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel solid-phase synthesis of mucin-like glycopeptides.
    Liu M; Barany G; Live D
    Carbohydr Res; 2005 Sep; 340(13):2111-22. PubMed ID: 16026772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1997 Apr; 272(15):9709-19. PubMed ID: 9092502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts.
    Inoue M; Takahashi S; Yamashina I; Kaibori M; Okumura T; Kamiyama Y; Vichier-Guerre S; Cantacuzène D; Nakada H
    Cancer Res; 2001 Feb; 61(3):950-6. PubMed ID: 11221889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
    Perrine CL; Ganguli A; Wu P; Bertozzi CR; Fritz TA; Raman J; Tabak LA; Gerken TA
    J Biol Chem; 2009 Jul; 284(30):20387-97. PubMed ID: 19460755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods in enzymology: O-glycosylation of proteins.
    Peter-Katalinić J
    Methods Enzymol; 2005; 405():139-71. PubMed ID: 16413314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational consequences of protein glycosylation: preparation of O-mannosyl serine and threonine building blocks, and their incorporation into glycopeptide sequences derived from alpha-dystroglycan.
    Liu M; Borgert A; Barany G; Live D
    Biopolymers; 2008; 90(3):358-68. PubMed ID: 17868094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct orders of GalNAc incorporation into a peptide with consecutive threonines.
    Kato K; Takeuchi H; Miyahara N; Kanoh A; Hassan H; Clausen H; Irimura T
    Biochem Biophys Res Commun; 2001 Sep; 287(1):110-5. PubMed ID: 11549261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
    Brockhausen I; Dowler T; Paulsen H
    Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
    Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
    Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
    Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
    Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
    Gerken TA; Zhang J; Levine J; Elhammer A
    J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.